Longevity Health Holdings, Inc. (NASDAQ:XAGE – Get Free Report) dropped 3.1% on Friday . The stock traded as low as $0.24 and last traded at $0.24. 134 shares traded hands during trading, a decline of 95% from the average session volume of 2,704 shares. The stock had previously closed at $0.2478.
Longevity Health Price Performance
The stock has a 50-day moving average price of $0.30 and a 200 day moving average price of $0.31. The firm has a market cap of $427,680.00, a price-to-earnings ratio of -0.06 and a beta of 0.39.
Longevity Health Company Profile
Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.
See Also
- Five stocks we like better than Longevity Health
- Why Wall Street Suddenly Sees SpaceX as an AI Company
- Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop
- Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs?
- The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story
Receive News & Ratings for Longevity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Longevity Health and related companies with MarketBeat.com's FREE daily email newsletter.
